| Product Name |
Dabigatran Inhouse Impurity 27 / Dabigatran Acid Cyano Analog
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Heterocycles, Bases and Related Reagents, Nucleotides, Fine Chemicals, Aromatics, Chiral Standards |
| CAS No |
212322-77-5 |
| Catalog Number |
GS.01.DAB.137 |
| Chemical Name/Synonyms |
3-({2-[(4-Cyanophenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic Acid; N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine; |
| Molecular Weight |
454.48 |
| Molecular Formula |
C25H22N6O3 |
| Purity |
NLT 95 % |
| Appearance |
Off-White to White Solid |
| Solubility |
DCM, Methanol |
| Applications |
Used to reduces the risk of stroke and systemic embolism in patients diagnosed with non-valvular atrial fibrillation. |
| Inventory Status |
QC Pending
|
